Department of Surgery, University of California, San Francisco, San Francisco, CA, USA.
Department of Surgery, Clarunis - St. Clara Hospital and University Hospital Basel, Basel, Switzerland.
BMC Surg. 2023 Aug 2;23(1):215. doi: 10.1186/s12893-023-02122-3.
The aim of this study was to investigate the associations between individual surgeon's intraoperative nerve monitoring (IONM) practice and factors associated with vocal cord (VC) dysfunction in patients with thyroid cancer undergoing thyroidectomy.
Using Collaborative Endocrine Surgery Quality Improvement Program (CESQIP) 2014-21 data, multivariable logistic regression analyses investigated variables associated with short- and long-term VC-dysfunction, associations of routine use of IONM with postoperative outcomes, and patient characteristics associated with IONM use.
Among 5,446 patients (76.7% female, mean age 49 years), 68.5% had surgery by surgeons using IONM in ≥ 90% of cases (63% of surgeons, n = 73). Post-operative VC-dysfunction was diagnosed by laryngoscopy in 3.0% of patients in the short-term and 2.7% in the long-term. When surgeons routinely used IONM, the incidence of VC-dysfunction was 2.4% in the short-term and 2.2% in the long-term, compared to 4.4% and 3.7%, respectively, when surgeons did not routinely use IONM (p < 0.01). After adjustment, routine use of IONM was independently associated with reduced risk of short- (OR 0.48, p < 0.01) and long-term (OR 0.52, p < 0.01) VC-dysfunction, a lower risk of postoperative hypoparathyroidism in the short- (OR 0.67, p < 0.01) and long-term (OR 0.54, p < 0.01), and higher likelihood of same-day discharge (OR 2.03, p < 0.01). Extrathyroidal tumor extension and N1-stage were factors associated with postoperative VC-dysfunction in the short- (OR 3.12, p < 0.01; OR 1.92, p = 0.01, respectively) and long-term (OR 3.11, p < 0.01; OR 2.32, p < 0.01, respectively).
Routine use of IONM was independently associated with a lower risk of endocrine surgery-specific complications and greater likelihood of same-day discharge.
本研究旨在探讨单个外科医生术中神经监测(IONM)实践与甲状腺癌患者甲状腺切除术相关声带(VC)功能障碍的因素之间的关联。
使用协作内分泌手术质量改进计划(CESQIP)2014-21 数据,多变量逻辑回归分析调查了与短期和长期 VC 功能障碍相关的变量,常规使用 IONM 与术后结果的关联,以及与 IONM 使用相关的患者特征。
在 5446 名患者(76.7%为女性,平均年龄 49 岁)中,68.5%的手术由术中 IONM 使用率≥90%的外科医生进行(63%的外科医生,n=73)。术后通过喉镜诊断 VC 功能障碍的发生率为短期 3.0%,长期 2.7%。当外科医生常规使用 IONM 时,短期和长期 VC 功能障碍的发生率分别为 2.4%和 2.2%,而当外科医生不常规使用 IONM 时,发生率分别为 4.4%和 3.7%(p<0.01)。调整后,常规使用 IONM 与短期(OR 0.48,p<0.01)和长期(OR 0.52,p<0.01)VC 功能障碍风险降低独立相关,与短期(OR 0.67,p<0.01)和长期(OR 0.54,p<0.01)术后甲状旁腺功能减退症风险降低相关,与当天出院的可能性更高(OR 2.03,p<0.01)。甲状腺外肿瘤延伸和 N1 期是短期(OR 3.12,p<0.01;OR 1.92,p=0.01)和长期(OR 3.11,p<0.01;OR 2.32,p<0.01)术后 VC 功能障碍的相关因素。
常规使用 IONM 与内分泌手术特定并发症风险降低和当天出院可能性增加独立相关。